CC BY 4.0 · Brazilian Journal of Oncology 2017; 13(45): e-BJO20171345A133
DOI: 10.26790/BJO20171345A133
Revisão

Low rectal cancer: current approach based on magnetic resonance imaging

Câncer de reto inferior: abordagem atual baseada na ressonância magnética
Marcus Valadão
1   Instituto Nacional de Cancer José Alencar Gomes da Silva - INCA, Rio de Janeiro, RJ, Brazil
,
Eduardo R.Z. Câmara
1   Instituto Nacional de Cancer José Alencar Gomes da Silva - INCA, Rio de Janeiro, RJ, Brazil
,
Rodrigo Araújo
1   Instituto Nacional de Cancer José Alencar Gomes da Silva - INCA, Rio de Janeiro, RJ, Brazil
,
José Paulo Jesus
1   Instituto Nacional de Cancer José Alencar Gomes da Silva - INCA, Rio de Janeiro, RJ, Brazil
,
Eduardo Linhares
1   Instituto Nacional de Cancer José Alencar Gomes da Silva - INCA, Rio de Janeiro, RJ, Brazil
,
Claudia Carrada
1   Instituto Nacional de Cancer José Alencar Gomes da Silva - INCA, Rio de Janeiro, RJ, Brazil
› Author Affiliations

Financial support: For the accomplishment of this work there was no aid or financial resources.

ABSTRACT

The complex anatomy surrounding lower rectal cancer, as well as its aggressive biological behavior, creates surgical challenges. Furthermore, patients with lower rectal cancer have a poorer prognosis, compared to tumors in the middle and upper rectum. Thus, it is essential to adopt new strategies to optimize the results of surgical treatment. Magnetic resonance imaging has become a crucial tool for successfully selecting and completing surgery, as it provides a high anatomical resolution and the ability to define the tumor’s relationship with the sphincter complex. New surgical techniques based on magnetic resonance imaging can also improve patients’ oncological and functional outcomes. This review examines the modern approach to treating lower rectal cancer, and aims to simplify the complex decisions that surgery currently requires. The PubMed database was searched using the terms “lower rectal cancer”, “colorectal surgery”, and “magnetic resonance imaging”. Milestone reports from recent years have been addressed in this review.

RESUMO

O câncer do reto inferior representa um desafio ao cirurgião, principalmente relacionada a complexidade anatômica e cirúrgica dessa região, além da questão biológica, visto que pacientes portadores de câncer do reto inferior apresentam pior resultado oncológico quando comparados aos tumores de reto médio e superior. Nesse contexto, torna-se fundamental a adoção de novas estratégias que visem a otimizar os resultados do seu tratamento. Nesse sentido, devido a alta resolução anatômica e a capacidade de definir a relação do tumor com o complexo esfincteriano, a ressonância magnética (RM) tornou-se ferramenta crucial para a escolha e sucesso da cirurgia. Além disso, novas técnicas cirúrgicas com base nas informações da ressonância tem propiciado melhores resultados oncológicos e funcionais para esses pacientes. O presente artigo revisa a abordagem moderna do câncer de reto inferior e tem o intuito de tornar mais simples a complexa decisão de como tratar cirurgicamente nos dias atuais esse tumor. Esse trabalho foi realizado com base na pesquisa no pubmed utilizando os termos “low rectal cancer”, “colorectal surgery”, magnetic ressonance imaging”. Os artigos considerados importantes marcos nesse assunto nos últimos anos foram abordados.



Publication History

Received: 30 July 2017

Accepted: 06 September 2017

Article published online:
25 February 2025

© 2017. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

Bibliographical Record
Marcus Valadão, Eduardo R.Z. Câmara, Rodrigo Araújo, José Paulo Jesus, Eduardo Linhares, Claudia Carrada. Low rectal cancer: current approach based on magnetic resonance imaging. Brazilian Journal of Oncology 2017; 13: e-BJO20171345A133.
DOI: 10.26790/BJO20171345A133
 
  • REFERENCES

  • 1 Iafrate F, Laghi A, Paolantonio P, Rengo M, Mercantini P, Ferri M, Ziparo V, Passariello R. Preoperative staging of rectal cancer with MR Imaging: correlation with surgical and histopathologic findings. Radiographics 2006; 26 (03) 701-14 Review
  • 2 Shihab OC, How P, West N, George C, Patel U, Quirke P, Heald RJ, Moran BJ, Brown G. Can a novel MRI staging system for low rectal cancer aid surgical planning?. Dis Colon Rectum 2011; 54 (10) 1260-4
  • 3 Shihab OC, Taylor F, Salerno G, Heald RJ, Quirke P, Moran BJ, Brown G. MRI predictive factors for long-term outcomes of low rectal tumours. Ann Surg Oncol 2011; 18 (12) 3278-84
  • 4 Nougaret S, Reinhold C, Mikhael HW, Rouanet P, Bibeau F, Brown G. The use of MR imaging in treatment planning for patients with rectal carcinoma: have youchecked the “DISTANCE”?. Radiology 2013; 268 (02) 330-44
  • 5 Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ. Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345 (09) 638-46
  • 6 Nagtegaal ID, van de Velde CJ, Marijnen CA, van Krieken JH, Quirke P. Dutch Colorectal Cancer Group. Pathology Review Committee. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 2005; 23 (36) 9257-64
  • 7 Salerno G, Daniels IR, Brown G. Magnetic resonance imaging of the low rectum: defining the radiological anatomy. Colorectal Dis 2006 08 Suppl 3 10-3 Review
  • 8 Shihab OC, Heald RJ, Rullier E, Brown G, Holm T, Quirke P, Moran BJ. Defining the surgical planes on MRI improves surgery for cancer of the low rectum. Lancet Oncol 2009; 10 (12) 1207-11
  • 9 Kusters M, Marijnen CA, van de Velde CJ, Rutten HJ, Lahaye MJ, Kim JH, Beets-Tan RG, Beets GL. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol 2010; 36 (05) 470-6
  • 10 Araujo RO, Valadão M, Borges D, Linhares E, de Jesus JP, Ferreira CG, Victorino AP, Vieira FM, Albagli R. Nonoperative management of rectal câncer after chemoradiation opposed to resection after complete clinical response. A comparative study. Eur J Surg Oncol 2015; 41 (11) 1456-63
  • 11 Shihab OC, Moran BJ, Heald RJ, Quirke P, Brown G. MRI staging of low rectal cancer. Eur Radiol 2009; 19 (03) 643-50
  • 12 Taylor FG, Swift RI, Blomqvist L, Brown G. A systematic approach to the interpretation of preoperative staging MRI for rectal cancer. AJR Am J Roentgenol 2008; 191 (06) 1827-35
  • 13 McBrearty A, McCallion K, Moorehead RJ, McAllister I, Mulholland K, Gilliland R, Campbell WJ. Re-Staging Following Long-Course Chemoradiotherapy For Rectal Cancer: Does It Influence Management?. Ulster Med J 2016; 85 (03) 178-81
  • 14 Engin G, Sharifov R. Magnetic resonance imaging for diagnosis and neoadjuvant treatment evaluation in locally advanced rectal cancer: A pictorial review. World J Clin Oncol 2017; 8 (03) 214-29
  • 15 De Nardi P, Carvello M. How reliable is current imaging in restaging rectal cancer after neoadjuvant therapy?. World J Gastroenterol 2013; 19 (36) 5964-72 Review
  • 16 Lee JH, Jang HS, Kim JG, Lee MA, Kim DY, Kim TH. et al. Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02. Radiother Oncol 2014; 113 (01) 18-23
  • 17 Hanly AM, Ryan EM, Rogers AC, McNamara DA, Madoff RD, Winter DC. MERRION Study Group. Multicenter Evaluation of Rectal cancer ReImaging pOst Neoadjuvant(MERRION) Therapy. Ann Surg 2014; 259 (04) 723-7
  • 18 Zhao RS, Wang H, Zhou ZY, Zhou Q, Mulholland MW. Re-staging of locally advanced rectal cancer with magnetic resonance imaging and endoluminal ultrasound after preoperative chemoradiotherapy: a systemic review and meta-analysis. Dis Colon Rectum 2014; 57 (03) 388-95
  • 19 Balyasnikova S, Brown G. Optimal Imaging Strategies for Rectal Cancer Staging and Ongoing Management. Curr Treat Options Oncol 2016; 17 (06) 32 Review
  • 20 Probst CP, Becerra AZ, Aquina CT, Tejani MA, Wexner SD, Garcia-Aguilar J, Remzi FH, Dietz DW, Monson JR, Fleming FJ. Consortium for Optimizing the Surgical Treatment of Rectal Cancer (OSTRiCh). Extended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation. J Am Coll Surg 2015; 221 (02) 430-40
  • 21 KSAR Study Group for Rectal Cancer. essential items for structured reporting of rectal cancer MRI: 2016 Consensus Recommendation from the Korean Society of Abdominal Radiology. Korean J Radiol 2017; 18 (01) 132-51